11 Cost Effectiveness in Preventing Crime  Jan van Busschbach, Djøra Soeteman  Viersprong Institute for studies on Personality Disorders VISPD  Erasmus.

Slides:



Advertisements
Similar presentations
ECONOMIC EVALUATION WHY DO YOU NEED TO BOTHER? JUDITH BOSMANS.
Advertisements

Health and Human Sciences Economics and Health: a taster Masters in Public Health Key reference: McPake B., Kumaranayake, L. & Normand, C (2002) Health.
Penny Wise and Effect Size Foolish Greg J. Duncan Northwestern University.
Should We Ration Health Care for Older People?
Implementation of new technologies Dr Keith Cooper Southampton Health Technology Assessments Centre University of Southampton.
COCOM Kwaliteit van leven in maat en getal Jan van Busschbach.
CHAPTER 6 BUDGETING How Will You Use Your Money?
We show that MP can be used to allocate resources to treatments within and between patient populations, using a policy-relevant example. The outcome is.
1 The Future of Quality of Life Assessment in Cost-Effectiveness Research Prof. Jan J. v. Busschbach, Ph.D. Erasmus MC Medical Psychology and Psychotherapy.
KINE 4565: The epidemiology of injury prevention Randomized controlled trials.
1 The QALYs debate  Prof. dr. Jan J.V. Busschbach, Ph.D.  Erasmus MC  Institute for Medical Psychology and Psychotherapy.
Money Management and Financial Planning
1 Does it make a difference for the patient? Survival & Quality of life  Jan J. v. Busschbach, Ph.D.  Erasmus MC Institute for Medical Psychology and.
1 A Health Economic View on Borderline Personality Disorder Prof. dr. Jan Busschbach Viersprong Institute for studies on Personality Disorders Medical.
(Cost-)Effectiveness of Psychotherapy for Personality Disorders Jan van Busschbach Prof. Dr. J. van Busschbach Department of Medical Psychology and Psychotherapy.
(Cost-)Effectiveness of Psychotherapy for Personality Disorders Prof. dr. Jan van Busschbach Department of Medical Psychology & Psychotherapy Erasmus MC.
1 Interactive Introduction cost effectiveness Jan J. v. Busschbach, Ph.D. Psychotherapeutic Centrum ‘De Viersprong’, Halsteren
A METHODOLOGY FOR MEASURING THE COST- UTILITY OF EARLY CHILDHOOD DEVELOPMENTAL INTERVENTIONS Quality of improved life opportunities (QILO)
Valuation issues Jan Sørensen, Health Economist CAST – Centre for Applied Health Services Research and Technology Assessment University of Southern Denmark.
The Use of Decision Analysis in Program Evaluation Farrokh Alemi, Ph.D.
The Benefits of Risk Factor Prevention in Americans Aged 51 Years and Older Dana P. Goldman, Federico Girosi et al. American Journal of Public Health November.
1 Dyslexia and Cost Effectiveness Prof. dr. Jan van Busschbach De Viersprong Erasmus MC.
Health Economics & Policy 3 rd Edition James W. Henderson Chapter 4 Economic Evaluation in Health Care.
1 EuroQol EQ-5D Jan J. V. Busschbach, Ph.D Psychotherapeutic Centrum ‘De Viersprong’, Halsteren Department of Medical.
Economic Evaluations, Briefly… CHSC 433 Module 6/Chapter 13 UIC School of Public Health L. Michele Issel, PhD, R N.
Enhanced Services- Programme Budgeting and Marginal Analysis Health Economics Team.
1 Cost-effectiveness in Personality Disorder Dr. J.J.V. Busschbach Psychotherapeutic centre ‘De Viersprong’ –PO Box AA Halsteren
Cost-Effectiveness Problem l You have a $1.5 billion budget to spend on any combination of these programs:
Economics of Implementation: Moving beyond Traditional CEA Mark Smith Paul Barnett VA Health Economics Resource Center.
AS Business Studies Budgets Today you will know what a budget is. You will understand why budgets are set and you will apply this to the case study Unit.
Knowing what you get for what you pay An introduction to cost effectiveness FETP India.
Cost-Effectiveness Thresholds Professor of Health Economics
BACKGROUND Cost-effectiveness of Psychotherapy for Cluster C Personality Disorders and the Value of Information and Implementation Djøra I. Soeteman 1,2,
1 Reconciliation of Economic Arguments and Clinical Practice Monday November 4, 2002 ISPOR, Rotterdam Jan Busschbach PhD, –Department of Medical Psychology.
Cost-effectiveness of psychotherapy for personality disorders Djøra Soeteman Viersprong Institute for Studies on Personality Disorders Erasmus Medical.
Mohammad Aljawadi PharmD, PhD Clinical Pharmacy Department King Saud University PHCL 431 Sep, 2015.
Interactive Introduction cost effectiveness Jan J. v. Busschbach, Ph.D Viersprong Institute for studies on Personality Disorders (VISPD)
1 Cost effectiveness as argument for reimbursement in prevention Jan J. v. Busschbach, Ph.D. Erasmus MC –Institute for Medical Psychology and Psychotherapy.
Economic evaluation of psychotherapy for personality disorders: burden of disease and cost-effectiveness Djøra Soeteman Viersprong Institute for Studies.
1 The Economic Burden of Personality Disorders  Djøra Soeteman, Jan J.V. Busschbach, Leona Hakkaart-van Roijen, Roel Verheul  Viersprong Institute for.
Quality of life and Cost-Effectiveness An Interactive Introduction Prof. Jan J. v. Busschbach, Ph.D. Erasmus MC Medical Psychology and Psychotherapy Viersprong.
Flagship Program on Health Sector Reform and Sustainable Financing.
1 The Cost Effectiveness of Treatment of Personality Disorder  Dr. Jan J.V. Busschbach  PTC De Viersprong, Erasmus MC, Rotterdam, 
Cost-Effectiveness of Psychotherapy for Personality Disorders Soeteman, Busschbach, Verheul.
Cost-effectiveness in the quest to convince the outside world Dr. Jan Busschbach De Viersprong Erasmus MC
1 Cost Effectiveness  Jan J.V. Busschbach, Ph.D.  Viersprong Institute for studies on Personality Disorders VISPD  Erasmus.
1 Interactive Introduction Cost Effectiveness and Psychotherapy Jan J. v. Busschbach, Ph.D. Psychotherapeutic Centrum ‘De Viersprong’, Halsteren
1 The Economics of Health Care and New Technologies Friday October 18, 2002 Between Technology and Humanity, Brussels Jan Busschbach PhD, –Department of.
2nd Concertation Meeting Brussels, September 8, 2011 Reinhard Prior, Scientific Coordinator, HIM Evidence in telemedicine: a literature review.
What are Ethics? ‘No small matter, but how should we live?’ (Plato ‘The Republic’) If a question includes the word ‘should’ then it may be an ethical one.
The financial costs and benefits of alcohol The financial costs and benefits of alcohol Christine Godfrey Department of Health Sciences & Centre for Health.
“Introduction to Patient Preference Methods used for QALYs” Presented by: Jan Busschbach, PhD, Chair Section Medical Psychology and Psychotherapy, Department.
Cost-Effectiveness and Outcomes Research Setting value to what we do.
Cost-Effectiveness of Psychotherapy (for Personality Disorders) Prof. dr. Jan van Busschbach.
THE DIABETES PREVENTION PROGRAM RESEARCH GROUP*
How to weight cost effectiveness in appraisal NVTAG / CVZ course: The appraisal process, work in progress 22th of April 2009 Jan van Busschbach.
(Cost-)Effectiveness of Psychotherapy for Personality Disorders Jan van Busschbach Prof. Dr. J. van Busschbach Department of Medical Psychology and Psychotherapy.
1 Quality of life and Cost-Effectiveness An Interactive Introduction Prof. Jan J. v. Busschbach, Ph.D. Erasmus MC Medical Psychology and Psychotherapy.
1 Cost-Effectiveness in Medicine An Interactive Introduction  Jan J. v. Busschbach, Ph.D.  Erasmus MC Institute for Medical Psychology and Psychotherapy.
Central American Certificate Course: HIV Monitoring and Evaluation for HIV/AIDS Policy and Program Management BZ ES GT NI PA CR Economic Evaluation and.
Economic Evaluation in D & I Research
Cost effectiveness Analysis: Valuing Health; Valuing Research!
HEALTH ECONOMICS BASICS
Providing Peace of Mind…
College of Public Health and Human Sciences
Health care decision making
Justification treatment cost
Presentation Developed for the Academy of Managed Care Pharmacy
Diabetic Retinopathy Clinical Research Network
Presentation transcript:

11 Cost Effectiveness in Preventing Crime  Jan van Busschbach, Djøra Soeteman  Viersprong Institute for studies on Personality Disorders VISPD  Erasmus MC Department of Medical Psychology and Psychotherapy

2 Reputation health economics

3 Reputation  Health economics….it is all about budgets…  “We didn’t actually overspend the budget….The Health Commission allocation simply fell short of our expenditure” (Keith Davis)

4 Health economics ≠ budget  It is more about what you can do, given a (fixed) budget…  Trade-off between effects  Given your budget

5 Do economics help….?  Te aim of a car is “transportation”  Cost effectiveness = Cost / km 5 Jeep Grand Cherokee 4.7….€ 1,143 per km (2006) Suzuki New Alto d glx Cool….. € 0.259

6 Cost effectiveness does not predict allocation….  Either  Cost effectiveness is invalid…  or discussion about the aim of the interventions The definition of the effects….  The effects are most often discussed  Not the budget calculations  Therefore guidelines  To obtain compatibility… 6

7 Few cost effectiveness studies  According to guidelines about a dozen  Non in The Netherlands  Welsh & Farrington, 2000  A review of the literature revealed only seven [7] published studies that have presented information on monetary costs and benefits.  McDougall et al., 2003  A systematic review of the literature revealed only nine [9] published studies that fit the criteria of the review.  Swaray et al., 2005  “10 studies fit the criteria of the review”

8 Build cost benefit studies on the basis of effect studies…. Steve Aos, Robert Barnoski, Roxanne Lieb

9 What they did….

10 16 interventions  Tax payer perspective  5 losses  11 gains  Societal perspective  3 losses  13 gains

11 Confirmation by formal Cost effectiveness studies The public costs and benefits per participant of the High/Scope Perry Preschool Study (Schweinhart, 2003).

12 Why seek further…  Interventions seem cost effective…  In terms of monetary cost benefit  What is the point of not implementing…?

13 Are we overlooking societal relevant outcomes…. 13 Jeep Grand Cherokee 4.7….€ 1,143 per km (2006) Suzuki New Alto d glx Cool….. € 0.259

14 Are we overlooking societal relevant outcomes?  Revenge (Genoegdoening)  What is the price of losing societal revenge….  If overlooked, cost effectiveness of alternatives are too optimistic  Do we agree what the effects of prevention should be?  If not….how can we determine cost effectiveness?  The question of economics is not technical…but fundamental

15 Not restricted to crime prevention in youth  Prevention in smoking costs money  When only valuing cost items…  As in diabetes etc  But the aim of prevention is to increase life expectation…  So value the increase of live expectation… “The aim of health care is not to save money but to save people from preventable suffering and death. Any potential savings on health care costs would be icing on the cake….” (Bonneux et al., 1998)

16 What is the value of life?

17 What is the value of life?

18 Or make life years the effect….  Cost per life year gained  Cost per quality of life adjusted year (QALY)

19 Generic outcomes  If we want to compare quite different treatment options…  Detention  Family Coaching  We can not use treatment specific outcomes  Numbers of days in jail  Family cohesion  Generic outcomes  That are relevant for both  That are relevant for the policy question

20 What are good generic outcomes in crime prevention?  Well….  Asking the question is answering it…  Crime! Cost per crime avoided Open for debate Quality of crime?  Treatment specific outcomes….  Like family cohesions  Might be relevant for the treatment  Are popular in scientists  But are of limited relevance for policy making….

21 Conclusion  The odds are favorable  Many alternatives are expensive  Many alternatives are ineffective  Choose societal relevant outcomes  Contains a fundamental discussion about the aim of prevention….  My favorite: Crime prevention